Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Main Study Treatment	STARTED	Riociguat (Adempas, BAY63-2521)	73
Main Study Treatment	STARTED	Placebo	74
Main Study Treatment	COMPLETED	Riociguat (Adempas, BAY63-2521)	33
Main Study Treatment	COMPLETED	Placebo	39
Main Study Treatment	NOT COMPLETED	Riociguat (Adempas, BAY63-2521)	40
Main Study Treatment	NOT COMPLETED	Placebo	35
Long-term Extension	STARTED	Riociguat (Adempas, BAY63-2521)	32
Long-term Extension	STARTED	Placebo	38
Long-term Extension	COMPLETED	Riociguat (Adempas, BAY63-2521)	0
Long-term Extension	COMPLETED	Placebo	0
Long-term Extension	NOT COMPLETED	Riociguat (Adempas, BAY63-2521)	32
Long-term Extension	NOT COMPLETED	Placebo	38
Safety Follow-up	STARTED	Riociguat (Adempas, BAY63-2521)	72
Safety Follow-up	STARTED	Placebo	64
Safety Follow-up	COMPLETED	Riociguat (Adempas, BAY63-2521)	50
Safety Follow-up	COMPLETED	Placebo	47
Safety Follow-up	NOT COMPLETED	Riociguat (Adempas, BAY63-2521)	22
Safety Follow-up	NOT COMPLETED	Placebo	17

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02138825/flow